Ion channels in sarcoma: pathophysiology and treatment options

Pflugers Arch. 2019 Sep;471(9):1163-1171. doi: 10.1007/s00424-019-02299-8. Epub 2019 Aug 3.

Abstract

Sarcomas are characterized by aggressive growth and a high metastasis potentially leading in most cases to a lethal outcome. These malignant tumors of the connective tissue have a high heterogeneity with numerous genetic mutations resulting in more than 100 types of sarcoma that can be grouped into two main kinds: soft tissue sarcoma and bone sarcoma. Sarcomas are often diagnosed at late disease stage, whereas a guaranteed diagnosis of the sarcoma type is fundamental for successful therapy. However, there is no appropriate therapy available. Therefore, the need for new therapies, which prolong survival and improve quality of life, is high. In the last two decades, the role of ion channels in cancer has emerged. Ion channels seem to be an ideal target for anti-tumor therapies. However, different cancer types have their own altered ion channel pattern, and the knowledge about the tumor-associated ion channel expression is fundamental. Here, we focus on the role of different ion channels in sarcoma, their pathophysiology, and possible treatment options.

Keywords: Bone sarcoma; Cancer; Ion channels; Sarcoma; Soft tissue sarcoma; Tumor.

Publication types

  • Review

MeSH terms

  • Animals
  • Bone Neoplasms / metabolism
  • Humans
  • Ion Channels / metabolism*
  • Quality of Life
  • Sarcoma / metabolism*
  • Soft Tissue Neoplasms / metabolism

Substances

  • Ion Channels